Thanks, Scott, and good morning, everyone. Reviewing our financial results in greater detail. I'll start by reiterating how pleased we are with our operational performance and backlog conversion, both of which helped drive results above our expectations for the third quarter. We generated our highest quarterly sales level in nearly eight years at $1.1 billion. And from that, we produced adjusted earnings per share of $0.50. The annual actuarial assessment of certain long-term liabilities slightly muted our results that would have otherwise been even stronger. This accrual resulted in a $10.7 million noncash expense to SG&A reducing both our reported and adjusted earnings per share by roughly $0.06. Based on our strong year-to-date performance and continued execution, we raised our revenue and adjusted EPS guidance ranges for the third consecutive quarter. This confidence comes from the improved and consistent operating performance of both segments, ongoing supportive end markets and the early benefits of our new organizational design. Third quarter reported earnings per share were $0.35, which includes $0.15 of net adjusted expenses, primarily realignment charges and below the line FX impact, but this was partially offset by the release of tax valuation allowance benefits. Revenue in the third quarter increased over 25% from the prior year, representing growth in nearly all aspects of the business. Original equipment and aftermarket revenues increased 28% and 23%, respectively, compared to the prior year. At the segment level, FPD's original equipment sales were particularly buoyant, delivering 45% year-over-year growth, while FCD contributed a solid 14% increase. While we maintain a near record aftermarket backlog at over $1 billion, third quarter aftermarket revenues increased markedly compared to prior year as well at 28% and 22% in FCD and FPD. All of our regions contributed double digit sales growth as well with notable year-over-year improvement in the Middle East and Africa, Latin America and North America of 51, 43% and 24%, respectively. Europe and Asia also delivered with substantial increases of 18% and 14%, respectively. Shifting to margins. we generated significant year-over-year improvement, reflecting the traction we've generated from our focus on operational excellence as well as the leverage benefit from our rising revenues in the quarter. Our adjusted gross margin increased 230 basis points year-over-year to 29.7%. Additional factors for the improvement include our price increases initiated over the last year and improved supply chain environment and reduce frictional costs. Partially offsetting these factors, however, were headwinds from the modest mix shift resulting from increased original equipment work, including some shipments of lower margin original equipment work from backlog that was booked in challenging market conditions as well as increased performance based compensation accruals. While we are pleased with our operating progress in year-to-date adjusted gross margin of 30.1%, this is a foundational level we intend to further improve upon. As you heard at our Analyst Day last month, we have defined a clear path to drive margin expansion through the combination of the new organizational design and are focused on operational excellence and product management that we believe are key levers for our longer term margin targets. We have consistently increased the margin in our backlog over the past year as visibility to end markets at our bookings levels have steadily improved. Additionally, the early benefits of our new organizational model enabled us to modestly exceed our $50 million annualized cost reduction goal where roughly 60% of the savings identified in action will benefit the cost of goods sold line. On a reported basis, third quarter gross margins increased 160 basis points to 29%, where in addition to the previously discussed items, the quarter was impacted by increased realignment charges of $7.6 million versus the prior year. Third quarter adjusted SG&A increased $11 million to $235 million compared to last year. The increase was primarily due to higher performance-based incentive accruals of $11 million as well as a $3 million increase in the annual true-up of the previously mentioned actuarially determined liabilities, which were partially offset by $6 million -- by a $6 million benefit from bad debt reversal. As a percent of sales, adjusted SG&A decreased 420 basis points to 21.4% as we successfully leveraged higher revenues and realized some early benefits from our 2023 cost-out plan. As we grow our revenues and maintain our cost focus, including benefits from the organizational redesign, we would expect to deliver results even better than these levels in the future. On a reported basis, third quarter SG&A increased year-over-year by $31 million to $252 million. In addition to the items just mentioned, our reported amount also includes a $21 million increase in adjusted items, primarily due to a $15 million increase in realignment expenses as we executed the cost reduction program and remaining expenses related to pursuing the Velan transaction. Despite the dollar increase year-over-year, reported SG&A as a percent of sales declined 230 basis points to 23%. Our third quarter adjusted operating margin increased 630 basis points to 8.7%, reflecting our strong operational performance, lower frictional costs and ongoing SG&A controls, partially offset by the actuarial expense at corporate, which impacted our margin level this quarter by approximately 100 basis points. By segment, FCD and FPD delivered momentum building results with adjusted segment operating margins of 14.7% and 12.3%, respectively. These margins represent year-over-year increases of 420 and 630 basis points, respectively. Third quarter reported operating margin increased 360 basis points year-over-year to 6.4%, where significant operating leverage and operational execution was partially offset by the $28 million increase in adjusted items versus prior year. Our adjusted tax rate was 11.2% in the third quarter and lower than our full year guidance range. This outcome was achieved primarily due to the geographical mix of income and the timing related to certain foreign tax credits. Our reported rate was even lower. In fact, it was negative due to a $13 million valuation allowance benefit, which we excluded from our adjusted results. Year-to-date, our adjusted tax rate of 18.3% is still well within our original guidance range of 18% to 20%, and we also expect to finish the full year 2023 within that range at approximately 20%. Turning to cash flow. We are pleased with our year-to-date operating cash flow of $131 million, which represents a $241 million improvement over prior year. In addition to delivering higher earnings, we reduced cash used for working capital by over $150 million despite growing revenue and our significant backlog. Third quarter operating cash flow of $81 million was also driven primarily by improved earnings and working capital performance. We have now delivered positive operating cash flow in each quarter this year demonstrating our focus beginning late last year to smooth out some seasonality and improve our cadence throughout the year. Even with the significant increase in revenues we've delivered in 2023, I am pleased that accounts receivable is a year-to-date modest source of cash, reflecting an $80 million improvement compared to prior year. Our collection efforts have been strong, evidenced by the eight day reduction in our days sales outstanding versus the prior year. Inventory, including contract assets and liabilities has also contributed to our working capital progress as we reduced the cash used by $21 million, bringing the year-to-date improvement up to $38 million. As a percent of sales, primary working capital supporting our near record backlog improved 170 basis points versus prior year to 30.5% and declined sequentially 140 basis points as well. We will remain focused on reducing our working capital investment to a level well below 30% of sales to our 25% to 27% target outlined at the Analyst Day, which we expect to achieve through supply chain improvements and our more consistent and predictable execution. Significant uses of cash in the third quarter included $26 million in dividends, $16 million in capital expenditures and a $10 million term loan debt reduction payment. While we achieved a nearly $240 million improvement in free cash flow in 2023 compared to prior year, we still expect to see more come in the traditional seasonally robust fourth quarter. Turning to our outlook for the fourth quarter. We expect to build on our operating momentum and deliver solid quarterly revenue and adjusted earnings once again. which results in our full year revenue guidance range of 18% to 19% with full year adjusted earnings per share of $1.95 to $2.05. At the midpoint, our full year adjusted earnings guidance represents an 80% increase over last year. We expect our markets to remain active, resulting in a full year book-to-bill greater than 1, increasing our year-over-year backlog to support 2024 growth. Our adjusted targets exclude identified realignment expenses of approximately $55 million as well as potential items that may occur during the year, such as below the line currency effects and the impact of other discrete items. Including the identified realignment spending and our other adjustments year-to-date, we expect our reported EPS in the range of $1.40 to $1.50. As I highlighted at our Analyst Day, we have a preliminary 2024 outlook that supports mid single digit revenue growth, adjusted operating margin improvement of approximately 100 basis points and adjusted EPS growth of 20% to 25%. This outcome would be meaningful progress and provide confidence on the path to achieving our longer term goals. Our early view was based on entering 2024 with a higher quality backlog and building on our 2023 performance with the new organizational model fully in place and designed to increase our speed, accountability and reduced costs. As usual, we plan to initiate our official guidance in early 2024. Until then, we believe that we have built a rock solid foundation this year and are focused on the right initiatives to drive growth and margin expansion through operational excellence and improved product portfolio management. Together, we will use these levers to keep Flowserve on the path to achieve our 2027 goals at $5 billion plus in organic revenue with adjusted operating margins in the 14% to 16% range to drive adjusted earnings over $4 per share. Let me now return the call over to Scott.